Skip to content
PubMed This is a summary of 13 peer-reviewed journal articles Updated
Neurology · Progressive leukoencephalopathy with ovarian failure

Supportive Care and Medical Management

At a Glance

AARS2-related leukoencephalopathy has no established treatment that stops or reverses the disease. Care is individualized and focuses on hormone replacement for ovarian insufficiency when appropriate, rehabilitation, symptom relief, health monitoring, and coordinated specialists.

Because AARS2-related leukoencephalopathy is a complex condition affecting multiple systems, there is no established, disease-modifying cure. Instead, management is supportive and generally extrapolated from POI, leukodystrophy, and mitochondrial-disease guidance [1][2]. This means a team of specialists works together to manage your specific symptoms, prevent complications, and maintain your quality of life for as long as possible.

(Note: While researchers have studied supplements like alanine or “coenzyme complexes” in isolated cases, no supplement or mitochondrial cocktail has been proven to alter the course of AARS2-related disease. Patients should not start or stop treatments without their clinician’s advice [3][4].)

Managing Ovarian Insufficiency and Health Risks

For those affected by Premature Ovarian Insufficiency (POI), replacing missing hormones is a major part of care when not medically contraindicated.

  • Hormone Replacement Therapy (HRT): General POI guidelines often recommend systemic estrogen replacement until around age 50 (the typical age of natural menopause) [5][6].
  • The Goal: The aim is to manage symptoms of low estrogen and reduce long-term health risks. Transdermal patches (placed on the skin) may have a lower risk of blood clots than oral pills, but they are not risk-free [5][7]. The route and dose must be individualized for personal risks.
  • Uterine Protection: If you still have your uterus, an added hormone called progestogen is necessary to protect the uterine lining from thickening [5][8].
  • Bone and Heart Benefits: Replacing estrogen is important for preserving bone mineral density and managing cardiovascular risk factors [9][10]. Routine, individualized risk assessment (like DEXA scans and lipid checks) is crucial.
  • Contraception: HRT does not reverse the brain disease, restore egg supply, or reliably prevent pregnancy. Because spontaneous ovulation can occasionally occur, contraception may be needed if pregnancy is not desired.

Neurological, Cardiac, and Physical Support

Neurological care focuses on “symptom-targeted” treatments to help you stay mobile and independent.

  • Motor Symptoms: If you experience spasticity (stiffness) or dystonia (twisting movements), doctors may prescribe muscle relaxants or other movement-disorder medications [1].
  • Physical and Occupational Therapy (PT/OT): Regular therapy is essential for managing ataxia (unsteadiness) and gait disturbances. Therapists can help with balance exercises and recommend assistive devices (like canes or braces) before they are urgently needed [1][11].
  • Cardiac Evaluation: Because the broader AARS2 spectrum includes cardiomyopathy, ask whether baseline or follow-up cardiac assessment (like an EKG or echocardiogram) is appropriate [1].
  • Seizure Management: If seizures occur, they must be managed with antiseizure medications [1].

Cognitive and Psychiatric Care

Because 86% of reported cases experienced cognitive changes and 70% faced psychiatric symptoms, mental health is a priority [1].

  • Mood Management: Depression and anxiety are common and can be treated with standard therapies and medications.
  • Cognitive Support: Working with a neuropsychologist can help you develop strategies to manage difficulties with memory, planning, and organization [1][12].

Building Your Care Team

Managing this condition requires a “home base” of specialists who communicate with one another:

  • Neurologist: The lead for monitoring brain health, gait, and seizures.
  • Reproductive Endocrinologist or Gynecologist: To manage HRT and monitor bone health [6][13].
  • Cardiologist: To monitor heart health when relevant.
  • Geneticist/Genetic Counselor: To provide guidance for family members and future planning [2].
  • Psychiatrist or Psychologist: To support emotional well-being and treat behavioral changes [12].
  • Rehabilitation Specialists: Including PT, OT, and sometimes speech-language pathologists for help with swallowing or communication [11].

Common questions in this guide

Is there a cure for AARS2-related leukoencephalopathy?
There is currently no established treatment that reverses or stops AARS2-related disease. Care is supportive and aims to manage neurological, ovarian, cardiac, cognitive, and emotional effects, prevent complications, and preserve independence and quality of life.
Could hormone replacement therapy help if I have ovarian insufficiency?
When there is no medical reason to avoid it, systemic estrogen replacement is often considered for premature ovarian insufficiency until about the usual age of menopause. It can help low-estrogen symptoms and protect bone and cardiovascular health, but the dose and route must be individualized. If you have a uterus, a progestogen is generally needed to protect its lining.
Does hormone replacement treat the brain disease or prevent pregnancy?
No. Hormone replacement does not reverse the neurological disease, restore egg supply, or reliably prevent pregnancy. If pregnancy is not desired, ask your clinician about contraception because spontaneous ovulation can occasionally occur.
How are movement problems such as stiffness and unsteadiness treated?
Treatment depends on the symptom and may include medicines for spasticity or dystonia, along with physical and occupational therapy. Therapy can support balance, walking, daily activities, and early use of canes, braces, or other assistive devices. Seizures, if they occur, are treated with antiseizure medication.
What specialists should be involved in my care?
A neurologist can coordinate brain, movement, and seizure care, while a reproductive endocrinologist or gynecologist manages ovarian insufficiency and hormone therapy. Cardiology, medical genetics, mental health, physical and occupational therapy, and speech-language specialists may be added based on symptoms and risks. Coordination among clinicians helps everyone monitor the same baseline.
What health checks are important with AARS2-related leukoencephalopathy?
Monitoring may include bone-density testing, blood pressure and lipid checks, and cardiac assessment such as an electrocardiogram or echocardiogram when appropriate. Clinicians may also track mood, cognition, walking, stiffness, seizures, swallowing, and communication. The schedule should be individualized to your symptoms, treatments, and medical history.
Can supplements change the course of AARS2-related disease?
Researchers have studied some supplements in isolated cases, but no supplement or mitochondrial cocktail has been proven to alter the course of AARS2-related disease. Talk with your clinician before starting or stopping any supplement.

Questions For You

Answer a question to get research tailored to you. Your answers are private.

Get notified when new evidence is published on leukoencephalopathy, progressive, with ovarian failure.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Given my specific history, are there any contraindications (like blood clots or estrogen-sensitive cancers) that would prevent me from starting Hormone Replacement Therapy?
  2. 2.What is the target dose of estradiol for me, and should we use a transdermal patch or an oral tablet for safety?
  3. 3.If I have a uterus, which progestogen will we use to protect the uterine lining, and how often will my bleeding patterns be monitored?
  4. 4.Who will manage my routine bone-density, blood-pressure, lipid, and cardiac risk assessments?
  5. 5.Can you help coordinate my care between neurology, endocrinology, cardiology, and physical therapy to ensure we are all monitoring the same 'baseline'?

References

References (13)
  1. 1

    The clinical, radiological and genetic spectrum AARS2-related leukoencephalopathy: a case series of 15 patients and review of the literature.

    Wade C, de Paiva ARB, Nóbrega PR, et al.

    Journal of neurology 2026; (273(7)).

    PMID: 42362900
  2. 2

    Primary mitochondrial diseases.

    Pizzamiglio C, Hanna MG, Pitceathly RDS

    Handbook of clinical neurology 2024; (204()):53-76 doi:10.1016/B978-0-323-99209-1.00004-1.

    PMID: 39322395
  3. 3

    Amino acid supplementation in patients affected by leukoencephalopathies associated with mitochondrial aminoacyl tRNA synthetase pathogenic variants: Pilot clinical trial in adults and review of literature.

    Catania A, Marchet S, Einvag K, et al.

    Molecular genetics and metabolism 2025; (146(3)):109259 doi:10.1016/j.ymgme.2025.109259.

    PMID: 41075682
  4. 4

    AARS2 leukoencephalopathy: A new variant of mitochondrial encephalomyopathy.

    Tang Y, Qin Q, Xing Y, et al.

    Molecular genetics & genomic medicine 2019; (7(4)):e00582 doi:10.1002/mgg3.582.

    PMID: 30706699
  5. 5

    Premature ovarian insufficiency: When ovaries retire early.

    Sugianto SRS, Webber L, Safdar Husain F, et al.

    Annals of the Academy of Medicine, Singapore 2025; (54(3)):178-191 doi:10.47102/annals-acadmedsg.2024227.

    PMID: 40178424
  6. 6

    The role of mitochondrial dysfunction and genetics in female infertility and premature ovarian insufficiency.

    Kline BL, Compton AG, Frazier AE, et al.

    Human reproduction update 2026; doi:10.1093/humupd/dmag022.

    PMID: 42616676
  7. 7

    Expert opinion by the Italian Society of Gynecology of the Third Age (SIGiTE) and the Italian Society of Menopause (SIM) on diagnosis and treatment of premature ovarian insufficiency.

    Capozzi A, Ambroggio S, Cagnacci A, et al.

    Minerva endocrinology 2026; (51(1)):88-95 doi:10.23736/S2724-6507.25.04422-7.

    PMID: 41212137
  8. 8

    Premature ovarian insufficiency - hormone replacement therapy and management of long-term consequences.

    Machura P, Grymowicz M, Rudnicka E, et al.

    Przeglad menopauzalny = Menopause review 2018; (17(3)):135-138 doi:10.5114/pm.2018.78559.

    PMID: 30357030
  9. 9

    Hormone therapy in women with premature ovarian insufficiency: a systematic review and meta-analysis.

    Gonçalves CR, Vasconcellos AS, Rodrigues TR, et al.

    Reproductive biomedicine online 2022; (44(6)):1143-1157 doi:10.1016/j.rbmo.2022.02.006.

    PMID: 35461762
  10. 10

    Impact of hormone therapy on the bone density of women with premature ovarian insufficiency: A systematic review.

    Costa GPO, Ferreira-Filho ES, Simoes RDS, et al.

    Maturitas 2023; (167()):105-112 doi:10.1016/j.maturitas.2022.09.011.

    PMID: 36368093
  11. 11

    Pearls & Oy-sters: AARS2 Leukodystrophy-Tremor and Tribulations.

    Green K, MacIver CL, Ebden S, et al.

    Neurology 2024; (102(8)):e209296 doi:10.1212/WNL.0000000000209296.

    PMID: 38507676
  12. 12

    The emerging neurological spectrum of AARS2-associated disorders.

    Parra SP, Heckers SH, Wilcox WR, et al.

    Parkinsonism & related disorders 2021; (93()):50-54 doi:10.1016/j.parkreldis.2021.10.031.

    PMID: 34784527
  13. 13

    Premature ovarian failure.

    Jankowska K

    Przeglad menopauzalny = Menopause review 2017; (16(2)):51-56 doi:10.5114/pm.2017.68592.

    PMID: 28721130

This page explains supportive care for AARS2-related leukoencephalopathy for informational purposes only and is not medical advice. Your neurology, reproductive-health, and other specialists should tailor hormone therapy, monitoring, and symptom treatment to your history.